Cargando…

Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study

BACKGROUND: Previous in vitro experiments of human polycystic kidney disease (PKD) cells reported that caffeine is a risk factor for the promotion of cyst enlargement in patients with autosomal dominant PKD (ADPKD). The relentless progression of ADPKD inclines the majority of physicians to advocate...

Descripción completa

Detalles Bibliográficos
Autores principales: Girardat-Rotar, Laura, Puhan, Milo A., Braun, Julia, Serra, Andreas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778163/
https://www.ncbi.nlm.nih.gov/pubmed/28386880
http://dx.doi.org/10.1007/s40620-017-0396-8
_version_ 1783294306658811904
author Girardat-Rotar, Laura
Puhan, Milo A.
Braun, Julia
Serra, Andreas L.
author_facet Girardat-Rotar, Laura
Puhan, Milo A.
Braun, Julia
Serra, Andreas L.
author_sort Girardat-Rotar, Laura
collection PubMed
description BACKGROUND: Previous in vitro experiments of human polycystic kidney disease (PKD) cells reported that caffeine is a risk factor for the promotion of cyst enlargement in patients with autosomal dominant PKD (ADPKD). The relentless progression of ADPKD inclines the majority of physicians to advocate minimization of caffeine consumption despite the absence of clinical data supporting such a recommendation so far. This is the first clinical study to assess prospectively the association between coffee consumption and disease progression in a longitudinal ADPKD cohort. METHODS: Information on coffee consumption and disease progression was collected at each follow-up visit using standardized measurement methods. The main model for the outcomes, kidney size (height-adjusted total kidney volume, htTKV) and kidney function (estimated glomerular filtration rate, eGFR), was a linear mixed model. Patients entered the on-going Swiss ADPKD study between 2006 and June 2014 and had at least 1 visit every year. The sample size of the study population was 151 with a median follow-up of 4 visits per patient and a median follow-up time of 4.38 years. RESULTS: After multivariate adjustment for age, smoking, hypertension, sex, body mass index and an interaction term (coffee*visit), coffee drinkers did not have a statistically significantly different kidney size compared to non-coffee drinkers (difference of −33.03 cm(3) height adjusted TKV, 95% confidence interval (CI) from −72.41 to 6.34, p = 0.10). After the same adjustment, there was no statistically significant difference in eGFR between coffee and non-coffee drinkers (2.03 ml/min/1.73 m(2), 95% CI from −0.31 to 4.31, p = 0.089). CONCLUSION: Data derived from our prospective longitudinal study do not confirm that drinking coffee is a risk factor for ADPKD progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40620-017-0396-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5778163
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-57781632018-02-01 Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study Girardat-Rotar, Laura Puhan, Milo A. Braun, Julia Serra, Andreas L. J Nephrol Original Article BACKGROUND: Previous in vitro experiments of human polycystic kidney disease (PKD) cells reported that caffeine is a risk factor for the promotion of cyst enlargement in patients with autosomal dominant PKD (ADPKD). The relentless progression of ADPKD inclines the majority of physicians to advocate minimization of caffeine consumption despite the absence of clinical data supporting such a recommendation so far. This is the first clinical study to assess prospectively the association between coffee consumption and disease progression in a longitudinal ADPKD cohort. METHODS: Information on coffee consumption and disease progression was collected at each follow-up visit using standardized measurement methods. The main model for the outcomes, kidney size (height-adjusted total kidney volume, htTKV) and kidney function (estimated glomerular filtration rate, eGFR), was a linear mixed model. Patients entered the on-going Swiss ADPKD study between 2006 and June 2014 and had at least 1 visit every year. The sample size of the study population was 151 with a median follow-up of 4 visits per patient and a median follow-up time of 4.38 years. RESULTS: After multivariate adjustment for age, smoking, hypertension, sex, body mass index and an interaction term (coffee*visit), coffee drinkers did not have a statistically significantly different kidney size compared to non-coffee drinkers (difference of −33.03 cm(3) height adjusted TKV, 95% confidence interval (CI) from −72.41 to 6.34, p = 0.10). After the same adjustment, there was no statistically significant difference in eGFR between coffee and non-coffee drinkers (2.03 ml/min/1.73 m(2), 95% CI from −0.31 to 4.31, p = 0.089). CONCLUSION: Data derived from our prospective longitudinal study do not confirm that drinking coffee is a risk factor for ADPKD progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40620-017-0396-8) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-04-06 2018 /pmc/articles/PMC5778163/ /pubmed/28386880 http://dx.doi.org/10.1007/s40620-017-0396-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Girardat-Rotar, Laura
Puhan, Milo A.
Braun, Julia
Serra, Andreas L.
Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study
title Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study
title_full Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study
title_fullStr Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study
title_full_unstemmed Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study
title_short Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study
title_sort long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the suisse adpkd, a prospective longitudinal cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778163/
https://www.ncbi.nlm.nih.gov/pubmed/28386880
http://dx.doi.org/10.1007/s40620-017-0396-8
work_keys_str_mv AT girardatrotarlaura longtermeffectofcoffeeconsumptiononautosomaldominantpolycystickidneysdiseaseprogressionresultsfromthesuisseadpkdaprospectivelongitudinalcohortstudy
AT puhanmiloa longtermeffectofcoffeeconsumptiononautosomaldominantpolycystickidneysdiseaseprogressionresultsfromthesuisseadpkdaprospectivelongitudinalcohortstudy
AT braunjulia longtermeffectofcoffeeconsumptiononautosomaldominantpolycystickidneysdiseaseprogressionresultsfromthesuisseadpkdaprospectivelongitudinalcohortstudy
AT serraandreasl longtermeffectofcoffeeconsumptiononautosomaldominantpolycystickidneysdiseaseprogressionresultsfromthesuisseadpkdaprospectivelongitudinalcohortstudy